Publicaciones en las que colabora con Antonio Monge Vega (20)

2004

  1. New 3-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazin-1-yl]-1-(5-substituted benzo[b]thiophen-3-yl)propanol derivatives with dual action at 5-HT 1A serotonin receptors and serotonin transporter as a new class of antidepressants

    Pharmazie, Vol. 59, Núm. 7, pp. 499-501

2002

  1. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors

    European Journal of Pharmacology, Vol. 442, Núm. 1-2, pp. 63-71

  2. New 3-[4-(3-substituted phenyl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)-propanol derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants

    Pharmazie, Vol. 57, Núm. 8, pp. 515-518

  3. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-2-yl)propane derivatives with dual action at 5-HT1a serotonin receptors and serotonin transporter as a new class of antidepressants

    Pharmazie, Vol. 57, Núm. 6, pp. 355-357

  4. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT1A receptors

    Journal of Medicinal Chemistry, Vol. 45, Núm. 19, pp. 4128-4139

2001

  1. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants

    Journal of Medicinal Chemistry, Vol. 44, Núm. 3, pp. 418-428

  2. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants

    European Journal of Medicinal Chemistry, Vol. 36, Núm. 1, pp. 55-61

2000

  1. Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin- 1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: Serotonin reuptake inhibition and 5-HT(1A) receptor antagonism

    Farmaco, Vol. 55, Núm. 5, pp. 345-353

1997

  1. Synthesis of new indoyl-1,3,4-oxadiazole and oxadiazine derivatives. Potential monoamine oxidase inhibitor activity

    Journal of Heterocyclic Chemistry, Vol. 34, Núm. 5, pp. 1527-1533

  2. Synthesis of thiophene carboxamide derivatives as serotonin 5-HT4 receptor agonists

    Farmaco, Vol. 52, Núm. 2, pp. 89-92

  3. VB20B7, a novel 5-HT-ergic agent with gastrokinetic activity. I. Interaction with 5-HT3 and 5-HT4 receptors

    Journal of Pharmacy and Pharmacology, Vol. 49, Núm. 1, pp. 58-65

  4. VB20B7, a novel 5-HT-ergic agent with gastrokinetic activity. II. Evaluation of the gastroprokinetic activity in rats and dogs

    Journal of Pharmacy and Pharmacology, Vol. 49, Núm. 1, pp. 66-73

1996

  1. Synthesis and 5-HT3affinity of new 3-substituted indoles at central nervous system

    Drug Design and Discovery, Vol. 14, Núm. 2, pp. 157-170

1995

  1. Inotropic and Chronotropic Effects of 4‐(4′‐n‐Butylaniline)‐7,8‐dimethoxy‐5H‐pyrimido[5,4–b]indole in Guinea‐pig Atria

    Journal of Pharmacy and Pharmacology, Vol. 47, Núm. 7, pp. 601-607

  2. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models

    Psychopharmacology, Vol. 117, Núm. 2, pp. 137-148

1994

  1. Synthesis of 2-Piperazinylbenzothiazole and 2-Piperazinylbenzoxazole Derivatives with 5-HT3 Antagonist and 5-HT4 Agonist Properties

    Journal of Medicinal Chemistry, Vol. 37, Núm. 9, pp. 1320-1325

1993

  1. Novel Antagonists of 5-HT3 Receptors. Synthesis and Biological Evaluation of Piperazinylquinoxaline Derivatives

    Journal of Medicinal Chemistry, Vol. 36, Núm. 19, pp. 2745-2750

  2. Pharmacological characterization of the vasodilator effect of DF-100, a new pyridazino[4,5-b]indole, in vascular smooth muscle

    Journal of Cardiovascular Pharmacology, Vol. 21, Núm. 1, pp. 89-94

1992

  1. Antihypertensive and vasodilator effect of A-80b, a new pyridazino indole derivative

    European Journal of Pharmacology, Vol. 219, Núm. 3-4, pp. 409-414

1991

  1. 1-Hydrazino-4-(3,5-dimethyl-1-pyrazolyl)-5H-pyrazino[4,5-b]indole. A new antihypertensive agent

    European Journal of Medicinal Chemistry